Preferred Label : tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine;
MeSH note : could be used in vaccination programs irrespective of the pre-vaccination status with
polysaccharide vaccine.;
MeSH synonym : MenACWY-TT;
Is substance : O;
Origin ID : C576777;
UMLS CUI : C3529849;
ATC code(s)
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
https://www.has-sante.fr/jcms/p_3183910/fr/recommandation-vaccinale-contre-les-meningocoques-des-serogroupes-a-c-w-et-y-revision-de-la-strategie-vaccinale-et-determination-de-la-place-des-vaccins-meningococciques-tetravalents
2021
false
false
false
France
vaccination
tetravalent meningococcal vaccine
meningococcal infections
Invasive meningococcal disease (disorder)
france
child
infant
adolescent
immunization, secondary
vaccines, conjugate
Meningitis ACW & Y vaccination (procedure)
meningococcal infections
vaccine potency
polysaccharides, bacterial
Immunogenicity, Vaccine
tetravalent meningococcal vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
CRM197 (non-toxic variant of diphtheria toxin)
immunization schedule
adult
public health guidelines
meningococcal vaccines
vaccination
meningococcal vaccines
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
bacterial proteins
---
http://www.has-sante.fr/portail/jcms/c_2041961/fr/nimenrix-vaccins-meningococciques-a-c-w135-et-y-conjugues
http://www.has-sante.fr/portail/jcms/c_2041961/fr/nimenrix
2015
false
France
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
guidelines for drug use
meningitis, meningococcal
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
vaccination
injections, intramuscular
meningococcal infections
neisseria meningitidis, serogroup a
vaccines, conjugate
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
meningococcal vaccines
meningococcal vaccines
polysaccharides, bacterial
tetanus toxoid
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
risk factors
infant
immunization schedule
immunization, secondary
drug interactions
child
adult
adolescent
treatment outcome
clinical trials, phase iii as topic
adaptive immunity
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00234
2013
false
false
false
Canada
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
drug information
meningococcal vaccines
---
http://www.has-sante.fr/portail/jcms/c_1352587/nimenrix
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12514_NIMENRIX_Insc_AVIS2_CT12514.pdf
2012
false
France
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
vaccination
injections, intramuscular
meningococcal infections
neisseria meningitidis, serogroup a
vaccines, conjugate
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
meningococcal vaccines
meningococcal vaccines
polysaccharides, bacterial
tetanus toxoid
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
risk factors
infant
immunization schedule
immunization, secondary
drug interactions
child
adult
adolescent
treatment outcome
clinical trials, phase iii as topic
adaptive immunity
---
https://www.ema.europa.eu/medicines/human/EPAR/Nimenrix
2012
false
United Kingdom
English
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
syndication feed
summary of product characteristics
package leaflet
drug evaluation
antibiotic therapy
drug approval
treatment outcome
adult
adolescent
child
infant
vaccination
vaccines, conjugate
vaccines, conjugate
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
meningococcal vaccines
meningococcal vaccines
neisseria meningitidis, serogroup a
meningococcal infections
meningitis, meningococcal
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup y
neisseria meningitidis, serogroup W-135
polysaccharides, bacterial
injections, intramuscular
drug interactions
pregnancy
breast feeding
meningococcal vaccines
meningococcal vaccines
---
